Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omadacycline vs linezolid in Chinese adults with ABSSSI
CTR20182151Phase 3Completed
- Sponsor
- Hangzhou Ausia Biological Technology
- Start
- Dec 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omadacycline in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Hangzhou Ausia Biological Technology. Started Dec 2018; status: completed.
02
Drugs
omadacycline
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on CTR20182151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182151.